151 filings
Page 2 of 8
8-K
1gz2g5xplh jo
31 May 23
Amendments to Articles of Incorporation or Bylaws
4:12pm
8-K
bdxzk3pb8z0uh7q244
8 May 23
Establishment Labs Reports Record First Quarter 2023 Financial Results
4:04pm
8-K
d78t pabti
27 Apr 23
Entry into a Material Definitive Agreement
4:01pm
424B5
vajdn52kvbsu xba
26 Apr 23
Prospectus supplement for primary offering
4:05pm
424B5
5yk8j39atl4yc44gd3to
24 Apr 23
Prospectus supplement for primary offering
4:56pm
S-3ASR
lf5q eiuowyebu67
24 Apr 23
Automatic shelf registration
4:31pm
8-K
mg7ip7
24 Apr 23
Establishment Labs Announces Preliminary Unaudited Results for First Quarter 2023
4:22pm
8-K
s81u0o2ukczcjlcomoo
20 Apr 23
Establishment Labs Notes Presentation of 3-Year Results from Motiva U.S. IDE Study at The Aesthetic Meeting 2023
4:13pm
ARS
c7r1abi2n1
12 Apr 23
Annual report to shareholders
5:23pm
DEFA14A
suui3e8v
12 Apr 23
Additional proxy soliciting materials
5:22pm
PRE 14A
wcu19yqn0y4310jn7lj
28 Mar 23
Preliminary proxy
5:08pm
S-8
zva bedv5uf3
1 Mar 23
Registration of securities for employees
5:08pm
8-K
o0wyo3tc
27 Feb 23
Results of Operations and Financial Condition
4:01pm
8-K
htfu0rgy0dyu a022i
11 Jan 23
Founder & CEO Establishment Labs JUAN JOSÉ CHACÓN-QUIRÓS JANUARY 12th, 2023 41 Annual J.P. Morgan Healthcare Conference st
8:04am
8-K
s4xhx yb5
9 Jan 23
Establishment Labs Announces Preliminary Unaudited Revenue for Fourth Quarter and Fiscal Year 2022
8:04am
8-K
73zbdjef
2 Dec 22
Departure of Directors or Certain Officers
4:03pm